Eradication of minimal residual disease during graft-versus-host reaction induced by abrupt discontinuation of immunosuppression following bone marrow transplantation in a patient with Ph1-ALL

Transplant International

Volumn 10, Issue 4, 1997, Pages 328-330

  Kanamori, Heiwa ^a   Sasaki, Shin ^a   Yamazaki, Etsuko ^a   Ueda, Seiji ^a   Hattori, Michiko ^b   Fukawa, Hitoshi ^b   Tamura, Tomohiko ^a   Harano, Hiroshi ^a   Matsuzaki, Michio ^c   Ogawa, Kouji ^a   Mohri, Hiroshi ^a   Okubo, Takao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Yokohama Ekisaikai Hospital   (Japan)

^c YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute lymphoblastic leukemia, minimal residual disease, GVHD; GVHD, acute lymphoblastic leukemia, minimal residual disease; Residual disease, GVHD, acute lymphoblastic leukemia

Indexed keywords

CYCLOSPORIN; ONCOPROTEIN; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; DIARRHEA; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; MALE; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIBLING; T LYMPHOCYTE;

ADULT; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HUMANS; IMMUNOSUPPRESSION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; NEOPLASM, RESIDUAL;

EID: 8544270154     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050065     Document Type: Article

References (16)

1. Collins RH Jr, Rogers ZR, Bennett M, Kumar V, Nikein A, Fay JW (1992) Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant 10: 391-395
2. Higano CS, Brixey M, Bryant EM, Durnam DM, Doney K, Sullivan KM, Singer JW (1990) Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect. Transplantation 50: 175-177
3. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RT, Zwaan FE, Bortin MM (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75: 555-562
4. Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ (1991) Graft-versus-leukemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukemia cells. Bone Marrow Transplant 8: 253-258
5. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieder D, Rhee F, Mittermueller J, Witte T, Holler E, Ansari H (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86: 2041-2050
6. Kumar L (1994) Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 12: 1710-1717
7. Miyamura K, Morishima Y, Tanimoto M, Saito H, Kojima S, Kodera Y, Mizutani S (1990) Prediction of clinical relapse after bone marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukemia. Lancet II: 890
8. Miyamura K, Barrett AJ, Kodera Y, Saito H (1994) Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant 14: 201-209
9. Odom LF, August CS, Githens JH, Humbert JR, Morse H, Peakman D, Sharma B, Rusnak SL, Johnson FB (1978) Remission of relapsed leukemia during a graft-versus-host reaction: a "graft-versus leukemia reaction" in man ? Lancet II: 537-540
10. Okamoto R, Harano H, Matsuzaki M, Motomura S, Maruta A, Kodama F, Mohri H, Okubo T (1995) Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting. Am J Clin Pathol 104: 510-516
11. Peterson FB, Appelbaum FR, Bigelow CL, Buckner CD, Clift RA, Sanders JE, Storb R, Sullivan KM, Weiden PL, Fefer A, Thomas ED (1989) High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. Bone Marrow Transplant 4: 483-488
12. Singer JW, Keating A, Ramberg R, McGuffin R, Sanders JE, Sale G, Fialkow PJ, Thomas ED (1983) Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: a case report with in vitro marow culture studies. Blood 62: 869-872
13. Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R (1995) Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 23: 1553-1562
14. Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, Brautbar C, Or R (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 87: 2195-2204
15. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Feter A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73: 1720-1728
16. Weiss L, Reich S, Slavin S (1990) Effect of cyclosporine A and methylprednisolone on the GVL effect across major histocompatibility barriers in mice following allogeneic bone marrow trans-plantation. Bone Marrow Transplant 6: 229-233